FDA Requires New Warnings For Norpramin

by Brian Herrington on December 3, 2009 · 0 comments

in Drug/Pharmaceutical News

On December 2, 2009, the Federal Drug Administration notified health care professionals that “extreme caution should be used when this drug is given to patients who have a family history of sudden death, cardiac dysrhythmias, and cardiac conduction disturbances; and that seizures precede cardiac dysrhythmias and death in some patients.”

Norpramin (desipramin) is a drug used to fight depression. The full text of the FDA letter can be found here.

Related posts:

  1. FDA: Add New Safety Information To Labels Of TNF Blockers Below is the text of the latest Medwatch release related...

Related posts brought to you by Yet Another Related Posts Plugin.

Leave a Comment

Previous post:

Next post:


Parse error: syntax error, unexpected '<' in /home1/bherring/public_html/wp-content/themes/thesis_16/footer.php on line 7